CDT (CDT Equity) Buyback Yield %: -633.67 (As of Jun. 29, 2026)


CDT CDT Equity Inc CDT
10 GF Score
Price $0.64
! 5 Warning Signs
View Full Analysis

What is CDT Equity Buyback Yield %?

CDT Equity CDT -10.81% 10 Buyback Yield % is -633.67 as of Jun. 29, 2026. GuruFocus rates CDT with a GF Score™ of 10/100. The stock has 5 warning signs investors should review. Among 743 Biotechnology companies, CDT Equity ranks worse than 98.79% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

CDT Equity's current buyback yield was -633.67%.

CDT Equity Buyback Yield % Historical Data

* Premium members only.

The historical data trend for CDT Equity's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CDT Equity Buyback Yield % Chart

CDT Equity Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
0.00 0.00 0.00 0.00 -665.52

CDT Equity Quarterly Data
Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -114.68 -178.77 -257.32 -665.52

CDT vs CLDI, DCOY, ACUT: Buyback Yield % Comparison

For the Biotechnology subindustry, CDT Equity's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CDT Equity Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CDT Equity's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where CDT Equity's Buyback Yield % falls into.


CDT
10GF Score
CDT Equity Inc CDT
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CDT Equity Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

CDT Equity's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-0.106 + 19.699) / 2.944
=-665.52%

CDT Equity's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (-0.106 + 19.699) / 2.944
=-665.52%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -633.67 mean?
CDT Equity (CDT) has a Buyback Yield % of -633.67 as of Jun. 29, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on CDT Equity and its competitors. According to the industry distribution chart, CDT Equity ranks #734 out of 743 companies in the Biotechnology industry, placing it in the top 98.8%.
Is CDT Equity's Buyback Yield % too high?
CDT Equity's current Buyback Yield % is -633.67. Based on the distribution chart, CDT Equity ranks #734 out of 743 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, CDT Equity has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does CDT Equity's Buyback Yield % compare to CLDI and DCOY?
According to the Biotechnology industry distribution chart, CDT Equity ranks #734 out of 743 companies for Buyback Yield %. This places CDT Equity in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on CDT Equity and its competitors. CDT Equity's current Buyback Yield % is -633.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CDT Equity stock overvalued right now?
CDT Equity (CDT) has a current Buyback Yield % of -633.67. The current Buyback Yield % is -633.67. CDT Equity's overall GF Score™ is 10/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For CDT Equity (CDT), the current Buyback Yield % is -633.67 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CDT Equity Business Description

Address 4581 Tamiami Trail North, Suite 200, Naples, FL, USA, 34103
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.
10GF Score

Get the complete analysis for CDT

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.64
Price